Skip to content
PubMed This is a summary of 28 peer-reviewed journal articles Updated
Infectious Disease

Why is the Dengue Critical Phase After the Fever Breaks?

At a Glance

The Dengue critical phase begins just as your fever drops to normal. Your immune system overreacts to the virus, causing blood vessels to leak fluid into surrounding tissues. This plasma leakage can dangerously lower blood pressure, making this 24-to-48-hour window the most severe period.

Your doctor is right: in Dengue fever, a broken fever does not always mean you are out of the woods. In fact, it marks the beginning of the critical phase [1][2]. The reason danger peaks now is due to a delayed, intense immune system reaction [3][4]. While the fever was fighting the virus, the virus was leaving behind a protein called NS1 [5][6]. As your temperature drops back to normal—a process called defervescence—your immune system launches a massive counterattack [7]. This overreaction accidentally damages the inner lining of your blood vessels, making them “leaky” [8][9]. Fluid escapes from your bloodstream into surrounding tissues, which can lower your blood pressure, even though you might feel a false sense of relief because the fever is gone [3][1].

Defervescence: A False Sense of Security

Defervescence is the medical term for when a fever breaks and your body temperature returns to normal (usually 3 to 7 days after the first symptoms) [1][2]. In many illnesses, this means you are recovering. In Dengue, however, defervescence is the exact trigger point for the critical phase [3].

During the days you had a high fever, the Dengue virus was rapidly multiplying in your body. By the time the fever breaks, the amount of virus in your blood has actually peaked and is starting to decline [3][10]. But the virus leaves behind a trail of disruption that your body is just beginning to respond to.

The Immune System Overdrive (The Cytokine Storm)

The Dengue virus produces a specific protein called NS1 (Non-Structural Protein 1) [5][6]. This protein acts like a red flag, over-stimulating your immune system. In response, your immune cells release massive amounts of inflammatory chemicals called cytokines [7][11].

When these chemicals flood your system all at once, it is known as a cytokine storm [7][12]. This storm reaches its maximum intensity right around the time the fever drops [3]. If this is your second time getting Dengue (a secondary infection), your immune system recognizes the virus and reacts even more aggressively, putting you at higher risk for severe complications [13][14].

Leaky Blood Vessels (Vascular Permeability)

The most dangerous effect of the cytokine storm and the NS1 protein is what they do to your blood vessels. They attack the endothelium, which is the delicate inner lining of your blood vessels [5][8].

Normally, the cells of this lining are packed tightly together, keeping the fluid part of your blood (the plasma) safely inside the vessels. But the immune overreaction causes these cells to pull apart slightly, compromising the barrier [8][9]. This condition is called vascular permeability or “leaky blood vessels” [15][16].

The damage doesn’t tear the blood vessels apart; it just makes them porous [16]. As a result, the watery plasma leaks out of the bloodstream and into surrounding spaces, like your abdomen or lungs [17][18].

The Risk of Plasma Leakage and Shock

Because plasma is leaking out of the blood vessels, the blood left behind becomes thicker and more concentrated. Doctors measure this by looking at your hematocrit, which is the percentage of red blood cells in your blood [19][20]. A rapidly rising hematocrit is a major warning sign that your blood vessels are leaking [21][22]. Concurrently, the number of platelets (cells that help blood clot) often drops dramatically [21][22].

If too much plasma leaks out, there won’t be enough fluid left in your bloodstream to keep your blood pressure up or deliver oxygen to your vital organs [23]. This rapid drop in blood pressure is called Dengue Shock Syndrome, and it can be life-threatening if not closely monitored and managed with carefully timed intravenous (IV) fluids [23][1].

This critical window typically lasts 24 to 48 hours [24][1]. While monitoring for warning signs, managing your care properly is vital:

  • Hydrate Aggressively: Because plasma is leaking out of your vessels, you need to replace it. Drinking Oral Rehydration Solutions (ORS), coconut water, or fruit juices is crucial to maintain hydration [25].
  • Avoid Dangerous Painkillers: Because your platelets are dropping, your blood cannot clot normally. You must absolutely avoid NSAIDs like aspirin, ibuprofen, or naproxen, as they increase the risk of severe internal bleeding [26][25]. For pain or lingering fever, only use acetaminophen (paracetamol) [26][27].

Warning Signs to Watch For

You and your care team must be vigilant. Warning signs that your body is experiencing severe plasma leakage include:

  • Severe abdominal pain or tenderness [21][28]
  • Persistent vomiting (at least 3 times in 24 hours) [21][28]
  • Bleeding from the gums, nose, or unusually easy bruising [21][19]
  • Feeling unusually lethargic, restless, or dizzy, especially when standing [21][19]

If you experience any of these symptoms at any time—especially as your fever begins to drop—seek medical attention immediately.

The Road to Recovery

How do you know when this dangerous 48-hour period is over? The transition to the true recovery phase happens when plasma stops leaking and your body starts reabsorbing the fluid it lost [24][25]. Doctors will see your hematocrit levels stabilize and your platelet count begin to rise [24][22]. At this point, your vital signs will stabilize, and you will truly be on the path to recovery [24][1].

Common questions in this guide

Why does Dengue get worse after the fever goes down?
When your fever drops to normal, a process called defervescence, your immune system launches a massive counterattack against the virus. This intense immune reaction causes blood vessels to become porous and leak fluid, which can rapidly lead to dangerous drops in blood pressure.
What is the critical phase of Dengue fever?
The critical phase is a dangerous 24 to 48-hour window that starts just as your fever returns to normal. During this time, you are at the highest risk for severe complications like plasma leakage, internal bleeding, and Dengue Shock Syndrome.
What warning signs should I watch for after my Dengue fever breaks?
You should seek immediate emergency care if you develop severe abdominal pain, persistent vomiting, extreme lethargy, dizziness when standing, or any bleeding from your gums, nose, or under the skin.
What medications should I avoid during the Dengue critical phase?
You must completely avoid NSAID painkillers like aspirin, ibuprofen, and naproxen. Because Dengue lowers your platelet count, these medications can prevent your blood from clotting and significantly increase your risk of severe internal bleeding.
How do doctors monitor for leaky blood vessels in Dengue?
Doctors closely monitor your hematocrit, which measures the percentage of red blood cells in your blood. A rapidly rising hematocrit means fluid is leaking out of your bloodstream, leaving the remaining blood thicker and more concentrated.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How frequently should my hematocrit and platelet levels be tested during this critical 48-hour window?
  2. 2.Are my current hematocrit levels rising, and do they indicate that I need intravenous (IV) fluids yet?
  3. 3.What specific over-the-counter medications are safe for me to take right now, and which ones must I avoid?
  4. 4.If I notice bleeding or severe abdominal pain at home, should I go to the emergency room or contact your office first?
  5. 5.How much oral rehydration solution should I be aiming to drink each day during this phase?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (28)
  1. 1

    Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.

    Her Z, Kam YW, Gan VC, et al.

    The Journal of infectious diseases 2017; (215(1)):42-51 doi:10.1093/infdis/jiw494.

    PMID: 28077582
  2. 2

    Serum fatty acids and progression from dengue fever to dengue haemorrhagic fever/dengue shock syndrome.

    Villamor E, Villar LA, Lozano-Parra A, et al.

    The British journal of nutrition 2018; (120(7)):787-796 doi:10.1017/S0007114518002039.

    PMID: 30105961
  3. 3

    Clinicopathological alteration of symptoms with serotype among dengue infected pediatric patients.

    Verma P, Banerjee S, Baskey U, et al.

    Journal of medical virology 2022; (94(9)):4348-4358 doi:10.1002/jmv.27862.

    PMID: 35578548
  4. 4

    Recent advances in understanding dengue.

    Halstead S

    F1000Research 2019; (8()) doi:10.12688/f1000research.19197.1.

    PMID: 31448083
  5. 5

    Pathogenesis of Dengue: Dawn of a New Era.

    Halstead SB

    F1000Research 2015; (4()).

    PMID: 26918141
  6. 6

    Dengue virus non-structural protein 1 activates the p38 MAPK pathway to decrease barrier integrity in primary human endothelial cells.

    Barbachano-Guerrero A, Endy TP, King CA

    The Journal of general virology 2020; (101(5)):484-496 doi:10.1099/jgv.0.001401.

    PMID: 32141809
  7. 7

    A new player in the game: platelet-derived extracellular vesicles in dengue hemorrhagic fever.

    Perez-Toledo M, Beristain-Covarrubias N

    Platelets 2020; (31(4)):412-414 doi:10.1080/09537104.2020.1755031.

    PMID: 32310724
  8. 8

    Correlation of host inflammatory cytokines and immune-related metabolites, but not viral NS1 protein, with disease severity of dengue virus infection.

    Soe HJ, Manikam R, Raju CS, et al.

    PloS one 2020; (15(8)):e0237141 doi:10.1371/journal.pone.0237141.

    PMID: 32764789
  9. 9

    Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections.

    Srivastava V, Godara P, Jena SP, et al.

    International journal of biological macromolecules 2024; (260(Pt 2)):129562 doi:10.1016/j.ijbiomac.2024.129562.

    PMID: 38246445
  10. 10

    Altered Moesin and Actin Cytoskeleton Protein Rearrangements Affect Transendothelial Permeability in Human Endothelial Cells upon Dengue Virus Infection and TNF-α Treatment.

    Suttitheptumrong A, Mahutchariyakul T, Rawarak N, et al.

    Viruses 2021; (13(10)) doi:10.3390/v13102042.

    PMID: 34696472
  11. 11

    Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection.

    Branche E, Tang WW, Viramontes KM, et al.

    Antiviral research 2018; (158()):1-7 doi:10.1016/j.antiviral.2018.07.022.

    PMID: 30071205
  12. 12

    Mice, myeloid cells, and dengue: a new model for unraveling vascular leakage mysteries.

    Kurosu T, Sakai Y, Ami Y, et al.

    Frontiers in microbiology 2024; (15()):1367672 doi:10.3389/fmicb.2024.1367672.

    PMID: 38550855
  13. 13

    Virus-Induced Pathogenic Antibodies: Lessons from Long COVID and Dengue Hemorrhage Fever.

    Sun DS, Lien TS, Chang HH

    International journal of molecular sciences 2025; (26(5)) doi:10.3390/ijms26051898.

    PMID: 40076527
  14. 14

    Progress towards understanding the pathogenesis of dengue hemorrhagic fever.

    Pang X, Zhang R, Cheng G

    Virologica Sinica 2017; (32(1)):16-22 doi:10.1007/s12250-016-3855-9.

    PMID: 27853992
  15. 15

    Plectin is Required for Trans-Endothelial Permeability: A Model of Plectin Dysfunction in Human Endothelial Cells After TNF-α Treatment and Dengue Virus Infection.

    Suttitheptumrong A, Rawarak N, Reamtong O, et al.

    Proteomics 2018; (18(23)):e1800215 doi:10.1002/pmic.201800215.

    PMID: 30365215
  16. 16

    DENV NS1 and MMP-9 cooperate to induce vascular leakage by altering endothelial cell adhesion and tight junction.

    Pan P, Li G, Shen M, et al.

    PLoS pathogens 2021; (17(7)):e1008603 doi:10.1371/journal.ppat.1008603.

    PMID: 34310658
  17. 17

    Early diagnostic markers in predicting the severity of dengue disease.

    Moras E, Achappa B, Murlimanju BV, et al.

    3 Biotech 2022; (12(10)):268 doi:10.1007/s13205-022-03334-9.

    PMID: 36091089
  18. 18

    Integrating Ultrasonographic and Biochemical Markers to Assess Dengue Severity in Critical Care: A Retrospective Study.

    Dey S, Gupta M, Mehrotra A, et al.

    Cureus 2025; (17(12)):e100016 doi:10.7759/cureus.100016.

    PMID: 41583288
  19. 19

    Predictive Factors for the Complications of Dengue Fever in Children: A Retrospective Analysis.

    Uthraraj NS, Sriraam LM, Hiriyur Prakash M, et al.

    Cureus 2022; (14(12)):e33027 doi:10.7759/cureus.33027.

    PMID: 36721616
  20. 20

    Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients.

    Rathore APS, Senanayake M, Athapathu AS, et al.

    Scientific reports 2020; (10(1)):11856 doi:10.1038/s41598-020-68844-z.

    PMID: 32678248
  21. 21

    Clinical predictors of severe dengue: a systematic review and meta-analysis.

    Tsheten T, Clements ACA, Gray DJ, et al.

    Infectious diseases of poverty 2021; (10(1)):123 doi:10.1186/s40249-021-00908-2.

    PMID: 34627388
  22. 22

    Gall Bladder Wall Thickening in Dengue Fever - Aid in Labelling Dengue Hemorrhagic Fever and a Marker of Severity.

    Adil B, Rabbani A, Ahmed S, et al.

    Cureus 2020; (12(11)):e11331 doi:10.7759/cureus.11331.

    PMID: 33304669
  23. 23

    Dengue: A Neglected Disease of Concern.

    Jisamerin J, Mohamedkalifa A, Gaur A, et al.

    Cureus 2021; (13(10)):e18500 doi:10.7759/cureus.18500.

    PMID: 34692260
  24. 24

    Utility of Atypical Lymphocytes and Large Immature Cells in Prediction of Dengue Severity.

    Peraka R, Koppula A, Muppala BS, Parsa MM

    The Journal of the Association of Physicians of India 2023; (71(11)):19-24 doi:10.59556/japi.71.0395.

    PMID: 38720491
  25. 25

    Dengue hemorrhagic fever: a growing global menace.

    Parveen S, Riaz Z, Saeed S, et al.

    Journal of water and health 2023; (21(11)):1632-1650 doi:10.2166/wh.2023.114.

    PMID: 38017595
  26. 26

    Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement.

    de Almeida RR, Paim B, de Oliveira SA, et al.

    Lung 2017; (195(4)):389-395 doi:10.1007/s00408-017-0021-6.

    PMID: 28612239
  27. 27

    Preparedness for the Dengue Epidemic: Vaccine as a Viable Approach.

    Zeyaullah M, Muzammil K, AlShahrani AM, et al.

    Vaccines 2022; (10(11)) doi:10.3390/vaccines10111940.

    PMID: 36423035
  28. 28

    Liver involvement in dengue: A systematic review.

    Campana V, Inizan C, Pommier JD, et al.

    Reviews in medical virology 2024; (34(4)):e2564 doi:10.1002/rmv.2564.

    PMID: 38923215

This page explains the pathophysiology of the Dengue fever critical phase for educational purposes only. Dengue can be a life-threatening emergency; always seek immediate medical attention if you experience warning signs like severe pain, vomiting, or bleeding.

Get notified when new evidence is published on Dengue fever.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.